These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12062858)

  • 1. Differential effect of PPARgamma2 variants in the development of type 2 diabetes between native Japanese and Japanese Americans.
    Nemoto M; Sasaki T; Deeb SS; Fujimoto WY; Tajima N
    Diabetes Res Clin Pract; 2002 Aug; 57(2):131-7. PubMed ID: 12062858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.
    Kao WH; Coresh J; Shuldiner AR; Boerwinkle E; Bray MS; Brancati FL;
    Diabetes; 2003 Jun; 52(6):1568-72. PubMed ID: 12765972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.
    Deeb SS; Fajas L; Nemoto M; Pihlajamäki J; Mykkänen L; Kuusisto J; Laakso M; Fujimoto W; Auwerx J
    Nat Genet; 1998 Nov; 20(3):284-7. PubMed ID: 9806549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.
    Stumvoll M; Stefan N; Fritsche A; Madaus A; Tschritter O; Koch M; Machicao F; Häring H
    J Mol Med (Berl); 2002 Jan; 80(1):33-8. PubMed ID: 11862322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.
    Malecki MT; Frey J; Klupa T; Skupien J; Walus M; Mlynarski W; Sieradzki J
    Diabetes Res Clin Pract; 2003 Nov; 62(2):105-11. PubMed ID: 14581147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.
    Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Auwerx J; Deeb SS; Amouyel P
    Int J Obes Relat Metab Disord; 2000 Feb; 24(2):195-9. PubMed ID: 10702770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
    Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK
    J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
    Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
    J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds.
    Hasstedt SJ; Ren QF; Teng K; Elbein SC
    J Clin Endocrinol Metab; 2001 Feb; 86(2):536-41. PubMed ID: 11158005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.
    Yen CJ; Beamer BA; Negri C; Silver K; Brown KA; Yarnall DP; Burns DK; Roth J; Shuldiner AR
    Biochem Biophys Res Commun; 1997 Dec; 241(2):270-4. PubMed ID: 9425261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese.
    Iwata E; Yamamoto I; Motomura T; Tsubakimori S; Nohnen S; Ohmoto M; Igarashi T; Azuma J
    Diabetes Res Clin Pract; 2003 Oct; 62(1):55-9. PubMed ID: 14581158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARgamma2 pro12Ala polymorphism and insulin resistance in Japanese hypertensive patients.
    Yamamoto J; Kageyama S; Nemoto M; Sasaki T; Sakurai T; Ishibashi K; Mimura A; Yokota K; Tajima N
    Hypertens Res; 2002 Jan; 25(1):25-9. PubMed ID: 11924722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.
    Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
    Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?
    Poulsen P; Andersen G; Fenger M; Hansen T; Echwald SM; Vølund A; Beck-Nielsen H; Pedersen O; Vaag A
    Diabetes; 2003 Jan; 52(1):194-8. PubMed ID: 12502512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
    Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y
    Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.
    Douglas JA; Erdos MR; Watanabe RM; Braun A; Johnston CL; Oeth P; Mohlke KL; Valle TT; Ehnholm C; Buchanan TA; Bergman RN; Collins FS; Boehnke M; Tuomilehto J
    Diabetes; 2001 Apr; 50(4):886-90. PubMed ID: 11289057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.